News | PET-CT | February 10, 2016

New Wisconsin Health and Wellness Center Chooses Toshiba’s PET/CT System

System improves the patient experience, diagnostic confidence and image quality

Toshiba Celesteion PET/CT, Fox Valley Hematology & Oncology

February 10, 2016 — Patients at Fox Valley Hematology & Oncology’s (FVHO) new cancer care center are receiving a better imaging experience and more accurate positron emission tomography/computed tomography (PET/CT) scans with Toshiba America Medical Systems Inc.’s Celesteion PET/CT system.

The new FVHO Health & Wellness Center, which opened in September 2015, will use the Celesteion PET/CT system to image and plan treatment for cancer patients, as well as open up a new service line in the future for orthopedic imaging.

“The Celesteion is a ‘one-stop-shop’ system that can perform PET and CT imaging all at once, which eliminates the need to schedule multiple appointments, making imaging easier and faster for staff and patients,” said Sheri Krueger, diagnostic center coordinator, FVHO Health & Wellness Center. “In our experience, the system produces phenomenal and clear images with little to no artifacts, especially with larger patients. Additionally, claustrophobic patients regularly comment on the system’s large bore, which gives them a feeling of openness and more room.”

Toshiba’s Celesteion PET/CT system delivers a more comfortable patient experience with what the company calls the industry’s largest bore (90 cm CT and 88 cm PET), an expansive field-of-view and time-of-flight imaging. The versatile system combines high-performance PET and CT for all radiation and oncology imaging needs, including tumor detection, treatment evaluation and CT simulation. Helping to ensure patient safety is not a choice, Celesteion comes standard with Toshiba’s advanced CT dose reduction technology, AIDR 3D.

For more information: www.medical.toshiba.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...